Abstract Geographic atrophy (GA) is the chronic loss of retinal pigment epithelium, photoreceptors and choriocapillaris, marking the dry late stage of age‐related macular degeneration (AMD). GA prevalence is expected to rise in the upcoming decades. Advanced GA leads to central scotomas, reducing visual acuity and quality of life, potentially resulting in profound central vision loss. GA shares features with various retinal diseases and can therefore be complicated to distinguish from mimicking diseases. While no cure exists for GA, therapies like pegcetacoplan and avacincaptad aim to slow atrophy growth, making an accurate diagnosis essential for effective treatment. Misdiagnosis can lead to inappropriate treatment recommendations, impacting patient health and financial burden. This paper outlines the similarities and differences among prevalent diseases such as late‐onset Stargardt disease, PRPH2‐associated disease and maternally inherited diabetes and deafness (MIDD), resembling GA to aid in accurate diagnosis.
Johanna M. Colijn, Frank G. Holz, Jeroen Pas, Carel Hoyng. Retinal dystrophies simulating geographic atrophy: A diagnostic challenge. // Acta Ophthalmologica. – 2026. – DOI: 10.1111/aos.70184. – URL: https://onlinelibrary.wiley.com/doi/10.1111/aos.70184?af=R
Johanna M. Colijn, Frank G. Holz, Jeroen Pas, & Carel Hoyng (2026). Retinal dystrophies simulating geographic atrophy: A diagnostic challenge. Acta Ophthalmologica. https://doi.org/10.1111/aos.70184
Johanna M. Colijn, et al. “Retinal dystrophies simulating geographic atrophy: A diagnostic challenge.” Acta Ophthalmologica, 2026. doi:10.1111/aos.70184.
@article{Colijn2026,
title = {Retinal dystrophies simulating geographic atrophy: A diagnostic challenge},
author = {Colijn, Johanna M. and Holz, Frank G. and Pas, Jeroen and Hoyng, Carel},
journal = {Acta Ophthalmologica},
year = {2026},
doi = {10.1111/aos.70184},
url = {https://onlinelibrary.wiley.com/doi/10.1111/aos.70184?af=R}
}
Abstract Purpose To compare the efficacy of intravitreal dexamethasone (DEX) implant‐based regimen versus ranibizumab‐based regimen for managing retinal exudation and complications in stage 3 Coats' disease. Methods Thirty‐seven eyes...
Abstract Foundation models are rapidly emerging as a major development in ophthalmic artificial intelligence, largely because they can achieve strong downstream performance with fewer labelled images than conventional supervised models,...
Abstract Purpose To evaluate intraretinal fluid (IRF) volume dynamics after switching from aflibercept 2 mg to faricimab in eyes with diabetic macular oedema (DME), stratified by prior response to aflibercept. Methods This retrospective...